Copper(II) complexes of methimazole, an anti Grave’s disease drug : Synthesis, characterization and its potential biological behavior as alkaline phosphatase inhibitor
Methimazole (MeimzH<b>)</b> is an anti-thyroid drug and the first choice for patients with Grave’s disease. Two new copper(II) complexes of this drug: [Cu(MeimzH)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>].0.5H<sub>2</sub>O and [Cu(MeimzH)<...
Guardado en:
| Autores principales: | Urquiza, Nora M., Manca, Silvia G., Moyano, María Alejandra, Dellmans, Raquel Arrieta, Lezama, Luis, Rojo, Teófilo, Naso, Luciana Gissella, Williams, Patricia Ana María, Ferrer, Evelina Gloria |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2009
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/133155 |
| Aporte de: |
Ejemplares similares
-
Antioxidants and methimazole in the treatment of Graves' disease: Effect on urinary malondialdehyde levels
por: Guerra, Liliana Noemí, et al.
Publicado: (2005) -
Antioxidants and methimazole in the treatment of Graves' disease: Effect on urinary malondialdehyde levels
por: Guerra, L.N., et al. -
In vitro experiments and infrared spectroscopy analysis of acid and alkaline phosphatase inhibition by vanadium complexes
por: Parente, Juliana Elena, et al.
Publicado: (2019) -
Model complexes with naturally occurring ligands (salicylglycine and imidazol) and the biometals copper and cobalt
por: Ferrer, Evelina Gloria, et al.
Publicado: (2004) -
The epidemiology and etiopathogenesis of graves’ disease
por: Saban, Melina, et al.
Publicado: (2023)